How to manage relapsed/refractory MCL - new agents and unmet needs
Are combination therapies more effective for the treatment of relapsed refractory CLL?
Using cell mass to determine response to treatment: A possible cure?
Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.
ASCO 2016 highlights for multiple myeloma